Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | TG4023 |
| Synonyms | |
| Therapy Description |
TG4023 (MVA-FCU1) is a modified vaccinia virus engineered to express enzymes that convert prodrug 5-FC to 5-FU, which may increase 5-FU concentration in tumors (PMID: 28177438). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| TG4023 | MVA-FCU1 | TG4023 (MVA-FCU1) is a modified vaccinia virus engineered to express enzymes that convert prodrug 5-FC to 5-FU, which may increase 5-FU concentration in tumors (PMID: 28177438). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|